Mesenteric panniculitis - Revision history

Ostermayer: Prepared the page for translation

2026-01-04T23:45:56Z

Prepared the page for translation

← Older revision		Revision as of 23:45, 4 January 2026
Line 1:		Line 1:
	<languages/>		<languages/>
	<translate>		<translate>


	==Background==		==Background==
Line 7:		Line 8:
	*A rare, benign, and chronic fibrosing inflammatory disease that affects the adipose tissue of the mesentery (of the small intestine and colon)<ref name="Issa" />.		*A rare, benign, and chronic fibrosing inflammatory disease that affects the adipose tissue of the mesentery (of the small intestine and colon)<ref name="Issa" />.
	*Occurs independently (specific cause unknown) or in association with other disorders<ref name="Issa" />		*Occurs independently (specific cause unknown) or in association with other disorders<ref name="Issa" />



Line 12:		Line 14:

	*[[Special:MyLanguage/Abdominal pain\|Abdominal pain]]		*[[Special:MyLanguage/Abdominal pain\|Abdominal pain]]



Line 21:		Line 24:
	*Regional increase in mesenteric fat density on abdominal CT (i.e. “misty mesentery”)		*Regional increase in mesenteric fat density on abdominal CT (i.e. “misty mesentery”)
	**May be confirmed by surgical biopsy		**May be confirmed by surgical biopsy



Line 31:		Line 35:

	*Chronic treatment includes workup of underlying etiology and consideration of medical therapy for severe/protracted disease (e.g. corticosteroids, cyclophosphamide, or azathioprine)		*Chronic treatment includes workup of underlying etiology and consideration of medical therapy for severe/protracted disease (e.g. corticosteroids, cyclophosphamide, or azathioprine)



Line 36:		Line 41:

	*Outpatient		*Outpatient



Line 41:		Line 47:

	*Overall prognosis is usually good and recurrence seems to be rare<ref name="Issa" />		*Overall prognosis is usually good and recurrence seems to be rare<ref name="Issa" />



Line 54:		Line 61:

	[[Category:GI]]		[[Category:GI]]

	</translate>		</translate>

Ostermayer: Prepared the page for translation

2026-01-04T23:45:33Z

Prepared the page for translation

← Older revision		Revision as of 23:45, 4 January 2026
Line 1:		Line 1:
			<languages/>
			<translate>

	==Background==		==Background==

	*Also known as sclerosing mesenteritis, mesenteric lipodystrophy, mesenteric sclerosis, retractile mesenteritis, mesenteric Weber-Christian disease, liposclerotic mesenteritis, lipomatosis and lipogranuloma of the mesentery<ref name="Issa">Issa I and Baydoun H. Mesenteric panniculitis: Various presentations and treatment regimens. World J Gastroenterol. 2009 Aug 14; 15(30): 3827–3830.</ref>		*Also known as sclerosing mesenteritis, mesenteric lipodystrophy, mesenteric sclerosis, retractile mesenteritis, mesenteric Weber-Christian disease, liposclerotic mesenteritis, lipomatosis and lipogranuloma of the mesentery<ref name="Issa">Issa I and Baydoun H. Mesenteric panniculitis: Various presentations and treatment regimens. World J Gastroenterol. 2009 Aug 14; 15(30): 3827–3830.</ref>
	*A rare, benign, and chronic fibrosing inflammatory disease that affects the adipose tissue of the mesentery (of the small intestine and colon)<ref name="Issa" />.		*A rare, benign, and chronic fibrosing inflammatory disease that affects the adipose tissue of the mesentery (of the small intestine and colon)<ref name="Issa" />.
	*Occurs independently (specific cause unknown) or in association with other disorders<ref name="Issa" />		*Occurs independently (specific cause unknown) or in association with other disorders<ref name="Issa" />


	==Clinical Features==		==Clinical Features==
	*[[Abdominal pain]]
			*[[Special:MyLanguage/Abdominal pain\|Abdominal pain]]


	==Differential Diagnosis==		==Differential Diagnosis==
Line 11:		Line 18:

	==Evaluation==		==Evaluation==

	*Regional increase in mesenteric fat density on abdominal CT (i.e. “misty mesentery”)		*Regional increase in mesenteric fat density on abdominal CT (i.e. “misty mesentery”)
	**May be confirmed by surgical biopsy		**May be confirmed by surgical biopsy


	==Management==		==Management==

	*Supportive ED treatment		*Supportive ED treatment

Line 21:		Line 31:

	*Chronic treatment includes workup of underlying etiology and consideration of medical therapy for severe/protracted disease (e.g. corticosteroids, cyclophosphamide, or azathioprine)		*Chronic treatment includes workup of underlying etiology and consideration of medical therapy for severe/protracted disease (e.g. corticosteroids, cyclophosphamide, or azathioprine)


	==Disposition==		==Disposition==

	*Outpatient		*Outpatient


	==Prognosis==		==Prognosis==

	*Overall prognosis is usually good and recurrence seems to be rare<ref name="Issa" />		*Overall prognosis is usually good and recurrence seems to be rare<ref name="Issa" />


	==See Also==		==See Also==
Line 35:		Line 50:

	==References==		==References==

	<references/>		<references/>

	[[Category:GI]]		[[Category:GI]]
			</translate>

Mholtz at 18:05, 27 June 2017

2017-06-27T18:05:25Z

← Older revision		Revision as of 18:05, 27 June 2017
Line 1:		Line 1:
	==Background==		==Background==
	*Also known as sclerosing mesenteritis, mesenteric lipodystrophy, mesenteric sclerosis, retractile mesenteritis, mesenteric Weber-Christian disease, liposclerotic mesenteritis, lipomatosis and lipogranuloma of the mesentery<ref>Issa I and Baydoun H. Mesenteric panniculitis: Various presentations and treatment regimens. World J Gastroenterol. 2009 Aug 14; 15(30): 3827–3830.</ref>		*Also known as sclerosing mesenteritis, mesenteric lipodystrophy, mesenteric sclerosis, retractile mesenteritis, mesenteric Weber-Christian disease, liposclerotic mesenteritis, lipomatosis and lipogranuloma of the mesentery<ref name="Issa">Issa I and Baydoun H. Mesenteric panniculitis: Various presentations and treatment regimens. World J Gastroenterol. 2009 Aug 14; 15(30): 3827–3830.</ref>
	*A rare, benign, and chronic fibrosing inflammatory disease that affects the adipose tissue of the mesentery (of the small intestine and colon)<ref>Issa ~~I and Baydoun H. Mesenteric panniculitis: Various presentations and treatment regimens. World J Gastroenterol. 2009 Aug 14; 15(30): 3827–3830.<~~/~~ref~~>.		*A rare, benign, and chronic fibrosing inflammatory disease that affects the adipose tissue of the mesentery (of the small intestine and colon)<ref name="Issa" />.
	*Occurs independently (specific cause unknown) or in association with other disorders <ref>Issa ~~I and Baydoun H. Mesenteric panniculitis: Various presentations and treatment regimens. World J Gastroenterol. 2009 Aug 14; 15(30): 3827–3830.<~~/~~ref~~>		*Occurs independently (specific cause unknown) or in association with other disorders<ref name="Issa" />

	==Clinical Features==		==Clinical Features==
Line 8:		Line 8:

	==Differential Diagnosis==		==Differential Diagnosis==


	==Evaluation==		==Evaluation==
Line 25:		Line 26:

	==Prognosis==		==Prognosis==
	*Overall prognosis is usually good and recurrence seems to be rare <ref>Issa ~~I and Baydoun H. Mesenteric panniculitis: Various presentations and treatment regimens. World J Gastroenterol. 2009 Aug 14; 15(30): 3827–3830.<~~/~~ref~~>		*Overall prognosis is usually good and recurrence seems to be rare<ref name="Issa" />

	==See Also==		==See Also==


	==External Links==		==External Links==


	==References==		==References==
	<references/>		<references/>

			[[Category:GI]]

Rossdonaldson1 at 17:16, 27 June 2017

2017-06-27T17:16:21Z

← Older revision		Revision as of 17:16, 27 June 2017
Line 2:		Line 2:
	*Also known as sclerosing mesenteritis, mesenteric lipodystrophy, mesenteric sclerosis, retractile mesenteritis, mesenteric Weber-Christian disease, liposclerotic mesenteritis, lipomatosis and lipogranuloma of the mesentery<ref>Issa I and Baydoun H. Mesenteric panniculitis: Various presentations and treatment regimens. World J Gastroenterol. 2009 Aug 14; 15(30): 3827–3830.</ref>		*Also known as sclerosing mesenteritis, mesenteric lipodystrophy, mesenteric sclerosis, retractile mesenteritis, mesenteric Weber-Christian disease, liposclerotic mesenteritis, lipomatosis and lipogranuloma of the mesentery<ref>Issa I and Baydoun H. Mesenteric panniculitis: Various presentations and treatment regimens. World J Gastroenterol. 2009 Aug 14; 15(30): 3827–3830.</ref>
	*A rare, benign, and chronic fibrosing inflammatory disease that affects the adipose tissue of the mesentery (of the small intestine and colon)<ref>Issa I and Baydoun H. Mesenteric panniculitis: Various presentations and treatment regimens. World J Gastroenterol. 2009 Aug 14; 15(30): 3827–3830.</ref>.		*A rare, benign, and chronic fibrosing inflammatory disease that affects the adipose tissue of the mesentery (of the small intestine and colon)<ref>Issa I and Baydoun H. Mesenteric panniculitis: Various presentations and treatment regimens. World J Gastroenterol. 2009 Aug 14; 15(30): 3827–3830.</ref>.
	*~~Specific~~ cause is unknown<ref>Issa I and Baydoun H. Mesenteric panniculitis: Various presentations and treatment regimens. World J Gastroenterol. 2009 Aug 14; 15(30): 3827–3830.</ref>		*Occurs independently (specific cause unknown) or in association with other disorders <ref>Issa I and Baydoun H. Mesenteric panniculitis: Various presentations and treatment regimens. World J Gastroenterol. 2009 Aug 14; 15(30): 3827–3830.</ref>

	==Clinical Features==		==Clinical Features==
Line 15:		Line 15:
	==Management==		==Management==
	*Supportive ED treatment		*Supportive ED treatment

			There is no standardized treatment, and it may consist of anti-inflammatory or immunosuppressive agents. We recommend resection only when the advanced inflammatory changes become irreversible or in cases of bowel obstruction


	*Chronic treatment includes workup of underlying etiology and consideration of medical therapy for severe/protracted disease (e.g. corticosteroids, cyclophosphamide, or azathioprine)		*Chronic treatment includes workup of underlying etiology and consideration of medical therapy for severe/protracted disease (e.g. corticosteroids, cyclophosphamide, or azathioprine)

	==Disposition==		==Disposition==
	*Outpatient		*Outpatient

			==Prognosis==
			*Overall prognosis is usually good and recurrence seems to be rare <ref>Issa I and Baydoun H. Mesenteric panniculitis: Various presentations and treatment regimens. World J Gastroenterol. 2009 Aug 14; 15(30): 3827–3830.</ref>

	==See Also==		==See Also==

Rossdonaldson1: /* Clinical Features */

2017-06-27T17:11:13Z

Clinical Features

← Older revision		Revision as of 17:11, 27 June 2017
Line 5:		Line 5:

	==Clinical Features==		==Clinical Features==
			*[[Abdominal pain]]

	==Differential Diagnosis==		==Differential Diagnosis==

Rossdonaldson1: /* Background */

2017-06-27T16:32:21Z

Background

← Older revision		Revision as of 16:32, 27 June 2017
Line 1:		Line 1:
	==Background==		==Background==
	*Also known as "sclerosing mesenteritis"		*Also known as sclerosing mesenteritis, mesenteric lipodystrophy, mesenteric sclerosis, retractile mesenteritis, mesenteric Weber-Christian disease, liposclerotic mesenteritis, lipomatosis and lipogranuloma of the mesentery<ref>Issa I and Baydoun H. Mesenteric panniculitis: Various presentations and treatment regimens. World J Gastroenterol. 2009 Aug 14; 15(30): 3827–3830.</ref>
	*A rare, benign, and chronic fibrosing inflammatory disease that affects the adipose tissue of the mesentery (of the small intestine and colon)<ref>Issa I and Baydoun H. Mesenteric panniculitis: Various presentations and treatment regimens. World J Gastroenterol. 2009 Aug 14; 15(30): 3827–3830.</ref>.		*A rare, benign, and chronic fibrosing inflammatory disease that affects the adipose tissue of the mesentery (of the small intestine and colon)<ref>Issa I and Baydoun H. Mesenteric panniculitis: Various presentations and treatment regimens. World J Gastroenterol. 2009 Aug 14; 15(30): 3827–3830.</ref>.
	*Specific cause is unknown<ref>Issa I and Baydoun H. Mesenteric panniculitis: Various presentations and treatment regimens. World J Gastroenterol. 2009 Aug 14; 15(30): 3827–3830.</ref>		*Specific cause is unknown<ref>Issa I and Baydoun H. Mesenteric panniculitis: Various presentations and treatment regimens. World J Gastroenterol. 2009 Aug 14; 15(30): 3827–3830.</ref>

Rossdonaldson1 at 16:30, 27 June 2017

2017-06-27T16:30:38Z

← Older revision		Revision as of 16:30, 27 June 2017
Line 1:		Line 1:
	==Background==		==Background==
	*Also known as "sclerosing mesenteritis"		*Also known as "sclerosing mesenteritis"
	*A rare, benign, and chronic fibrosing inflammatory disease that affects the adipose tissue of the mesentery (of the small intestine and colon)<ref>Issa I and Baydoun H. Mesenteric panniculitis: Various presentations and treatment regimens. World J Gastroenterol. 2009 Aug 14; 15(30): 3827–3830.</ref>		*A rare, benign, and chronic fibrosing inflammatory disease that affects the adipose tissue of the mesentery (of the small intestine and colon)<ref>Issa I and Baydoun H. Mesenteric panniculitis: Various presentations and treatment regimens. World J Gastroenterol. 2009 Aug 14; 15(30): 3827–3830.</ref>.
	*Specific cause is unknown)<ref>Issa I and Baydoun H. Mesenteric panniculitis: Various presentations and treatment regimens. World J Gastroenterol. 2009 Aug 14; 15(30): 3827–3830.</ref>		*Specific cause is unknown<ref>Issa I and Baydoun H. Mesenteric panniculitis: Various presentations and treatment regimens. World J Gastroenterol. 2009 Aug 14; 15(30): 3827–3830.</ref>

	==Clinical Features==		==Clinical Features==
Line 11:		Line 11:
	==Evaluation==		==Evaluation==
	*Regional increase in mesenteric fat density on abdominal CT (i.e. “misty mesentery”)		*Regional increase in mesenteric fat density on abdominal CT (i.e. “misty mesentery”)
			**May be confirmed by surgical biopsy

	==Management==		==Management==
			*Supportive ED treatment
			*Chronic treatment includes workup of underlying etiology and consideration of medical therapy for severe/protracted disease (e.g. corticosteroids, cyclophosphamide, or azathioprine)

	==Disposition==		==Disposition==
			*Outpatient

	==See Also==		==See Also==

Rossdonaldson1 at 16:18, 27 June 2017

2017-06-27T16:18:16Z

← Older revision		Revision as of 16:18, 27 June 2017
Line 1:		Line 1:
	==Background==		==Background==
	*Also known as "sclerosing mesenteritis"		*Also known as "sclerosing mesenteritis"
			*A rare, benign, and chronic fibrosing inflammatory disease that affects the adipose tissue of the mesentery (of the small intestine and colon)<ref>Issa I and Baydoun H. Mesenteric panniculitis: Various presentations and treatment regimens. World J Gastroenterol. 2009 Aug 14; 15(30): 3827–3830.</ref>
			*Specific cause is unknown)<ref>Issa I and Baydoun H. Mesenteric panniculitis: Various presentations and treatment regimens. World J Gastroenterol. 2009 Aug 14; 15(30): 3827–3830.</ref>

	==Clinical Features==		==Clinical Features==
	~~<ref>Issa I and Baydoun H. Mesenteric panniculitis: Various presentations and treatment regimens. World J Gastroenterol. 2009 Aug 14; 15(30): 3827–3830.</ref>~~

	==Differential Diagnosis==		==Differential Diagnosis==

Rossdonaldson1 at 16:09, 27 June 2017

2017-06-27T16:09:08Z

← Older revision		Revision as of 16:09, 27 June 2017
Line 3:		Line 3:

	==Clinical Features==		==Clinical Features==
			<ref>Issa I and Baydoun H. Mesenteric panniculitis: Various presentations and treatment regimens. World J Gastroenterol. 2009 Aug 14; 15(30): 3827–3830.</ref>

	==Differential Diagnosis==		==Differential Diagnosis==

Rossdonaldson1: /* Evaluation */

2017-06-27T16:00:07Z

Evaluation

← Older revision		Revision as of 16:00, 27 June 2017
Line 7:		Line 7:

	==Evaluation==		==Evaluation==
			*Regional increase in mesenteric fat density on abdominal CT (i.e. “misty mesentery”)

	==Management==		==Management==